Nimer Assy is a full professor of Medicine and Head of the Department of Internal Medicine at Galilee Medical Center, Bar Ilan University, Israel. He obtained his MD in 1987 at Louvain (UCL), Belgium, and acquired his post-graduate training in internal medicine in 1990–94 from Rambam Hospital, Haifa. From 1994 to 1996 he was a clinical fellow in the Liver Unit at the University of Manitoba and the University of Western Ontario, Canada. From 1996 to 1999 he was the hepatology consultant at Rambam Hospital, Haifa, Technion, Israel. In 1999 he moved to Safed and developed the liver disease unit in the Ziv Medical Center and he was the Head of the Liver Unit from 2006 to 2014. In 2007 he was an assistant professor in the division of medicine at the Technion Institute. In the laboratory, his work has focused on the expression of cytokines in fatty liver diseases. His work in this area has led to important discoveries regarding the associations between hepatic fatty liver disease, soft drinks and coronary artery disease. His clinical research activities have largely been in the area of viral hepatitis (B and C). He also contributes mostly to the treatment of NAFLD and the contribution of liver fat accumulation to coronary artery diseases. He has served as the principal investigator on studies that involve the investigation and treatment of viral hepatitis B and C. He also served as an active member (Treasurer) of the Israeli Association for the Study of Liver Disease (IASL).